Author: wdd8007
-
Iron Accumulation Linked with Age-Related Cognitive Decline
Age-related breakdowns in regulatory mechanisms cause iron to build up in the brain, increasing oxidative stress and causing cellular damage, according to a recent Northwestern Medicine study.
-
New Alternative for Relapsed B-Cell Lymphoma
A new therapy showed improvements over the standard treatment for relapsed B-cell lymphoma, according to a recent study.
-
Northwestern Celebrates Martin Luther King, Jr. with Dream Week
Feinberg celebrated the life and work of the Rev. Dr. Martin Luther King, Jr. with Dream Week, featuring a candlelight vigil, an oratorical contest and conversations with Nikole Hannah-Jones.
-
Rogers Honored by National Academy of Sciences
John Rogers, PhD, has been awarded the 2022 James Prize in Science and Technology Integration by the Council of the National Academy of Sciences.
-
Without Coronary Calcium, Risk Factors Impact Cardiovascular Disease
Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension have the highest risk of cardiovascular disease events, according to a recent study.
-
Genome Editing Made Possible on Cells Lining Blood Vessel Walls
The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.
-
Improving Pre-Surgical Workups for Epilepsy
Using MRI, EEG and clinical characteristics, the pre-surgical workup can predict if patients with epilepsy will benefit from a more invasive examination.
-
Northwestern Medical Orchestra Returns to Stage
The Northwestern Medical Orchestra has returned to the stage, performing part of their concert in-person for the first time in nearly two years.
-
New Autism Biomarker Discovered in Cerebrospinal Fluid
Northwestern Medicine scientists have discovered a biomarker for one type of autism within cerebrospinal fluid, according to a recent study.
-
Microspheres Delay Progression of Colon Cancer
A recent study showed that targeted radioembolization alongside chemotherapy improved progress-free survival for patients with metastatic colon cancer.
